IRIS - Res&Arch Institutional Research Information System - Research & Archive

CHIAPPALUPI, SARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.777
AS - Asia 1.708
EU - Europa 1.646
SA - Sud America 348
Continente sconosciuto - Info sul continente non disponibili 181
AF - Africa 58
OC - Oceania 12
Totale 6.730
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.665
SG - Singapore 747
IT - Italia 645
BR - Brasile 276
CN - Cina 249
IE - Irlanda 206
HK - Hong Kong 204
RU - Federazione Russa 159
DE - Germania 112
VN - Vietnam 98
KR - Corea 90
FR - Francia 89
BD - Bangladesh 63
GB - Regno Unito 62
SE - Svezia 61
CA - Canada 57
NL - Olanda 56
IN - India 52
FI - Finlandia 48
RO - Romania 40
AT - Austria 32
UA - Ucraina 32
PH - Filippine 27
TR - Turchia 27
JP - Giappone 26
IQ - Iraq 25
MX - Messico 24
CO - Colombia 21
ZA - Sudafrica 21
PL - Polonia 19
ES - Italia 18
BE - Belgio 15
AR - Argentina 14
PK - Pakistan 14
EC - Ecuador 11
CH - Svizzera 10
SA - Arabia Saudita 10
AU - Australia 9
UZ - Uzbekistan 9
ID - Indonesia 8
CR - Costa Rica 7
LT - Lituania 7
MA - Marocco 7
PY - Paraguay 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
IR - Iran 6
JM - Giamaica 6
TN - Tunisia 6
VE - Venezuela 6
AZ - Azerbaigian 5
CZ - Repubblica Ceca 5
IL - Israele 5
LB - Libano 5
MD - Moldavia 5
MY - Malesia 5
TW - Taiwan 5
AL - Albania 4
EG - Egitto 4
JO - Giordania 4
KH - Cambogia 4
UY - Uruguay 4
BA - Bosnia-Erzegovina 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
GR - Grecia 3
HU - Ungheria 3
KZ - Kazakistan 3
NZ - Nuova Zelanda 3
OM - Oman 3
PA - Panama 3
PE - Perù 3
BY - Bielorussia 2
CW - ???statistics.table.value.countryCode.CW??? 2
DK - Danimarca 2
DZ - Algeria 2
EE - Estonia 2
EU - Europa 2
GE - Georgia 2
KE - Kenya 2
KG - Kirghizistan 2
NI - Nicaragua 2
NP - Nepal 2
PR - Porto Rico 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TT - Trinidad e Tobago 2
TZ - Tanzania 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BB - Barbados 1
CV - Capo Verde 1
DJ - Gibuti 1
GA - Gabon 1
GP - Guadalupe 1
GT - Guatemala 1
IS - Islanda 1
LV - Lettonia 1
ML - Mali 1
MQ - Martinica 1
Totale 6.545
Salva come PNG Salva come JPEG
Città #
Singapore 576
San Jose 271
Ashburn 265
Chandler 253
Dublin 202
Perugia 196
Hong Kong 192
Santa Clara 104
San Mateo 89
Boardman 77
Council Bluffs 69
Moscow 67
Los Angeles 62
The Dalles 62
Beijing 61
Lauterbourg 51
New York 47
Dearborn 44
Redmond 44
Princeton 42
Medford 41
Altamura 40
Ann Arbor 40
Munich 40
Wilmington 38
Seoul 36
Bucharest 34
Ho Chi Minh City 31
São Paulo 30
Turin 30
Bologna 28
Vienna 28
Andover 26
Lawrence 23
Dallas 22
Montreal 20
Falls Church 19
Piscataway 19
Rome 19
Seongnam-si 19
Tokyo 18
Milan 17
Orem 17
Phoenix 17
Hanoi 16
Brooklyn 15
Brussels 15
Amsterdam 14
Atlanta 14
Denver 14
Johannesburg 14
Cebu City 13
Falkenstein 13
Boston 12
Norwalk 12
Toronto 12
Helsinki 11
Jacksonville 11
London 11
North Bergen 11
Nuremberg 11
Warsaw 11
Houston 10
Saint Petersburg 10
Turku 10
Baghdad 9
Brasília 9
Parma 9
Redwood City 9
San Francisco 9
Da Nang 8
Frankfurt am Main 8
Groningen 8
Istanbul 8
Mumbai 8
Tijuana 8
Buffalo 7
Chennai 7
Columbus 7
Dhaka 7
Florence 7
Hefei 7
Naples 7
Rio de Janeiro 7
Shanghai 7
Stockholm 7
Woodbridge 7
Charlotte 6
Collazzone 6
Des Moines 6
Glasgow 6
Incheon 6
Tashkent 6
Trinity 6
Baku 5
Belo Horizonte 5
Chicago 5
Dong Ket 5
Jakarta 5
Lahore 5
Totale 3.928
Salva come PNG Salva come JPEG
Nome #
Beneficial effects of horsetail (Equisetum arvense) in experimental models of sarcopenia and osteoporosis 292
Pharmacological targeting of the receptor for advanced glycation end-products (RAGE) to counteract cancer cachexia 204
Histological muscle characterization in hypertrophied Marchigiana cattle breed 202
Intraperitoneal injection of microencapsulated Sertoli cells restores muscle morphology and performance in dystrophic mice 184
IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII 175
Targeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia 163
RAGE in the pathophysiology of skeletal muscle. 157
Identification of natural products able to counteract the formation of advanced glycation end-products (AGEs) sustaining muscle atrophy 157
Equisetum arvense standardized extract hinders age-related sarcopenia 151
Generation of an mdx/Ager–/– double mutant mouse. Preliminary data on skeletal muscle architecture. 148
Identification of Withania somnifera-Silybum marianum-Trigonella foenum-graecum Formulation as a Nutritional Supplement to Contrast Muscle Atrophy and Sarcopenia 148
Toward the identification of receptor for advanced glycation end-products (RAGE) as a muscle biomarker of cancer cachexia. 147
S100B protein regulates myoblast and macrophage functions in skeletal muscle regeneration 147
Ablation of RAGE (receptor for advanced glycation end-products) translates into reduced tumorigenic and cachectic potential in LLC-tumor bearing mice 143
Sertoli cells protect C2C12 myotubes against atrophy and induce utrophin expression in canine and human dystrophic myotubes. 143
Absence of RAGE in an animal experimental model of Duchenne muscular dystrophy results in reduced muscle necrosis and inflammation 143
Natural products to counteract muscle atrophy 143
Effects of intraperitoneal injection of microencapsulated Sertoli cells on chronic and presymptomatic dystrophic mice 138
RAGE and its ligands, S100B and HMGB1, are molecular determinants of cancer-induced muscle wasting. 138
Sertoli cell-secreted factors have promyogenic and antifibrotic properties on human DMD myoblasts with different mutations. 137
Targeting RAGE as a potential therapeutic approach to Duchenne muscular dystrophy 132
Involvement of a RAGE/p38MAPK/myogenin axis in cancer cachexia. 123
Mdx/Ager–/– mice show reduced muscle necrosis and inflammation compared with mdx mice 119
Employment of Microencapsulated Sertoli Cells as a New Tool to Treat Duchenne Muscular Dystrophy 118
KYMASIN UP Natural Product Inhibits Osteoclastogenesis and Improves Osteoblast Activity by Modulating Src and p38 MAPK 117
The effects of microgravity on human skeletal muscle regeneration. 116
Beneficial effects of horsetail (Equisetum arvense) in in vitro models of sarcopenia and osteoporosis 115
Receptor for advanced glycation end-products (RAGE) as a biomarker of muscle wasting in cancer conditions 114
Microencapsulated Sertoli cells sustain myoblast proliferation without affecting the myogenic potential. In vitro data 113
Transplantation of microencapsulated Sertoli cells: a new potential antiinflammatory approach to Duchenne muscular dystrophy (DMD). 112
Equisetum arvense standardized dried extract hinders age-related osteosarcopenia. 110
Do porcine Sertoli cells represent an opportunity for Duchenne muscular dystrophy? 110
Levels of S100B protein drive the reparative process in acute muscle injury and muscular dystrophy 109
Hyperactivated rage in comorbidities as a risk factor for severe covid-19—the role of rage-ras crosstalk 108
Defective RAGE activity in embryonal rhabdomyosarcoma cells results in high PAX7 levels that sustain migration and invasiveness 106
S100 proteins in obesity: liaisons dangereuses 106
Use of Sertoli cells to treat DMD patients is supported by their immunomodulatory rather than immunosuppressive effect 106
Reductive stress in striated muscle cells 105
Novel data support the use of microencapsulated Sertoli cells as a potential treatment of DMD patients. 104
Transplantation of microencapsulated Sertoli cells in mdx mice reduces muscle inflammation and promotes muscle regeneration 102
The receptor RAGE: a potential molecular target in cancer cachexia 101
Sertoli cells induce utrophin expression in human DMD myotubes with different mutations and exert promyogenic and antifibrotic effects 98
RAGE expression in rhabdomyosarcoma cells modulates metastasis formation in vivo. 97
HEREGULIN-INDUCED UTROPHIN UPREGULATION PROMOTES RECOVERY OF MUSCLE HOMEOSTASIS IN MDX MICE TRANSPLANTED WITH MICROENAPSULATED SERTOLI CELLS 97
Transplantation of microencapsulated Sertoli cells in a mouse model of Duchenne muscular dystrophy (DMD) reduces inflammation and rescues muscle performance. 94
Intraperitoneal transplantation of microencapsulated Sertoli cells counteracts muscle inflammation and rescues muscle performance in mdx mice. 84
The novel DMD experimental model, mdx/Ager–/– mouse reveals a role of RAGE in inflammatory processes in dystrophic muscles. 82
Sertoli cells improve myogenic differentiation, reduce fibrogenic markers, and induce utrophin expression in human dmd myoblasts 82
Self-powered temperature sensors harnessing membrane potential of living cells 81
Grafted Sertoli Cells Exert Immunomodulatory Non-Immunosuppressive Effects in Preclinical Models of Infection and Cancer 81
Targeting RAGE to prevent SARS-CoV-2-mediated multiple organ failure: Hypotheses and perspectives 80
The MyoGravity project to study real microgravity effects on human muscle precursor cells and tissue 73
Preparation of Human Muscle Precursor Cells for the MyoGravity Project - Cell Culture in Experiment Units for Space Flight Purpose 70
Sertoli cells have promyogenic and antifibrotic effects, and induce utrophin expression in human DMD myotubes with different mutations in a heregulin β1/ErbB2/ERK1/2-dependent manner 58
Diet-Derived Advanced Glycation End-Products (AGEs) Induce Muscle Wasting In Vitro, and a Standardized Vaccinium macrocarpon Extract Restrains AGE Formation and AGE-Dependent C2C12 Myotube Atrophy 36
RAGE Re-Expressed at Myofibre Level Drives Muscle Wasting in Cancer Conditions 11
Totale 6.730
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.890
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.890
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022342 0 0 0 19 12 12 12 106 12 39 58 72
2022/2023717 43 128 5 64 60 77 1 34 269 2 27 7
2023/2024387 18 28 9 35 18 12 102 8 19 24 37 77
2024/20251.448 46 103 148 84 166 68 136 153 195 87 186 76
2025/20262.375 140 116 96 276 308 206 384 155 229 195 211 59
2026/2027735 166 78 143 348 0 0 0 0 0 0 0 0
Totale 6.730